Progestins and endometrial cancer.

Premenopausal women--especially young women--with endometrial cancer stage I may be treated successfully with progestins alone as primary therapy to preserve their child-bearing potential. There is some indication that progestins could be used in neoadjuvant fashion. Individualization of adjuvant treatment with radiation or progestins and in combination seems possible. Progestins have an established place in the palliative treatment of women with advanced cancer. In addition, progestins can be used in advanced and/or recurrent endometrial cancer in combination with chemotherapy and tamoxifen.
AuthorsA E Schindler
JournalGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (Gynecol Endocrinol) Vol. 15 Suppl 6 Pg. 29-36 (Dec 2001) ISSN: 0951-3590 [Print] England
PMID12227884 (Publication Type: Journal Article, Review)
Chemical References
  • Estrogen Antagonists
  • Progestins
  • Tamoxifen
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Combined Modality Therapy
  • Endometrial Neoplasms (drug therapy, pathology, radiotherapy)
  • Estrogen Antagonists (therapeutic use)
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local (drug therapy)
  • Premenopause
  • Progestins (administration & dosage, therapeutic use)
  • Risk Factors
  • Tamoxifen (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: